Literature DB >> 1537361

Effect of a long-term methionyl growth hormone treatment on growth hormone releasing hormone-induced growth hormone secretion in patients with constitutional growth delay.

A Sartorio, A Conti, F Morabito, G Faglia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1537361     DOI： 10.1007/bf01958965

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  8 in total

1.  Effect of prolonged clonidine administration on growth hormone concentrations and rate of linear growth in children with constitutional growth delay.

Authors:  M Castro-Magaña; M Angulo; B Fuentes; M E Castelar; A Cañas; B Espinoza
Journal:  J Pediatr       Date:  1986-11       Impact factor: 4.406

2.  Exogenous growth hormone inhibits growth hormone-releasing factor-induced growth hormone secretion in normal men.

Authors:  S M Rosenthal; J A Hulse; S L Kaplan; M M Grumbach
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

3.  Suppression of the growth hormone (GH) response to clonidine and GH-releasing hormone by exogenous GH.

Authors:  J M Nakamoto; J M Gertner; C M Press; R L Hintz; R G Rosenfeld; M Genel
Journal:  J Clin Endocrinol Metab       Date:  1986-05       Impact factor: 5.958

4.  Preservation of physiological growth hormone (GH) secretion in idiopathic short stature after recombinant GH therapy.

Authors:  R H Wu; Y St Louis; J DiMartino-Nardi; S Wesoly; E H Sobel; B Sherman; P Saenger
Journal:  J Clin Endocrinol Metab       Date:  1990-06       Impact factor: 5.958

5.  Clonidine treatment for short stature.

Authors:  C Pintor; S G Cella; S Loche; R Puggioni; R Corda; V Locatelli; E E Müller
Journal:  Lancet       Date:  1987-05-30       Impact factor: 79.321

6.  Effect of two consecutive administrations of GHRH in children with constitutional growth delay.

Authors:  A Sartorio; A Spada; A Conti; F Morabito; G Faglia
Journal:  Eur J Pediatr       Date:  1990-07       Impact factor: 3.183

7.  Idiopathic short stature: results of a one-year controlled study of human growth hormone treatment. Genentech Collaborative Study Group.

Authors: 
Journal:  J Pediatr       Date:  1989-11       Impact factor: 4.406

8.  Short-term met-hGH infusion inhibits somatotroph response to growth hormone releasing hormone (1-44).

Authors:  M Rosenbaum; S Loche; S Balzano; J M Gertner
Journal:  Metabolism       Date:  1988-02       Impact factor: 8.694
  8 in total
  3 in total

1.  GHRH-induced GH responses during recombinant GH treatment in patients with short stature.

Authors:  A Sartorio; A Spada; A Conti; M Monzani; G Faglia
Journal:  J Endocrinol Invest       Date:  1993-05       Impact factor: 4.256

2.  Effect of chronic treatment with biosynthetic growth hormone (GH) on the GH response to double GH-releasing hormone administration in children with short stature.

Authors:  M Scacchi; L Danesi; A I Pincelli; A Dubini; F Cavagnini
Journal:  J Endocrinol Invest       Date:  1997-02       Impact factor: 4.256

3.  Galanin infusion restores the blunted GH responses to GHRH administration during GH treatment in children with constitutional growth delay.

Authors:  A Sartorio; A Conti; M Monzani; G Faglia
Journal:  J Endocrinol Invest       Date:  1995-02       Impact factor: 4.256
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.